Companies: 10,795·Total market cap: $144.5T
Global Cord Blood Corporation

Global Cord Blood Corporation

CORBFOTCHealthcare● Active
$0.95
+$0.00(+0.00%)
Market Cap$127218975
P/E Ratio
52W High$1.75
52W Low$0.2

Global Cord Blood Corporation(CORBF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CORBF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-032021-032020-032019-032018-03
Revenue
Revenue$1.24B$1.16B$1.22B$0.99B$0.94B
Cost of Revenue$0.18B$0.18B$0.19B$0.19B$0.18B
Gross Profit$1.06B$0.98B$1.03B$0.80B$0.76B
Gross Margin %(computed)85.26%84.57%84.52%81.15%80.63%
Operating Expenses
R&D Expenses$0.02B$0.02B$0.02B$0.01B$0.01B
G&A Expenses$0.19B$0.17B$0.19B$0.17B$0.24B
Total Operating Expenses$0.45B$0.44B$0.47B$0.42B$0.48B
Operating Income$0.61B$0.54B$0.56B$0.38B$0.28B
Operating Margin %(computed)48.97%46.99%45.77%38.68%29.88%
Interest Income$0.03B$0.03B$0.03B$0.03B$0.02B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.63B$0.61B$0.58B$0.36B$0.30B
Income Tax Expense$0.12B$0.09B$0.10B$0.06B$0.06B
Net Income$0.50B$0.51B$0.47B$0.29B$0.24B
Net Margin %(computed)40.30%43.83%38.54%29.50%25.31%
Per Share & EBITDA
EPS (Basic)$4.12$4.18$3.87$2.40$1.99
Wtd Avg Shares0.12B0.12B0.12B0.12B0.12B
EBITDA$0.66B$0.59B$0.61B$0.43B$0.35B
EBITDA Margin %(computed)52.83%51.22%49.82%43.98%37.75%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CNY · B

深入了解Global Cord Blood Corporation

关于Global Cord Blood Corporation(CORBF)损益表

Global Cord Blood Corporation(CORBF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,CORBF实现营收$1.24B,毛利润$1.06B(毛利率85.26%),净利润$0.50B(净利率40.30%)。

常见问题

CORBF · 4 问

Global Cord Blood Corporation(CORBF)2022财年营收为$1.24B,同比up7.2%。

CORBF revenueCORBF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09